Theralase AUA Pesentation at annual meetingIf the Theralase presentation over the weekend was well received at the AUA annual meeting the stock will do well over the medium to long time frame. Posters that are nitpicking the numbers may have fun but these posts are not very relevant to the overall process. Theralase will either get FDA approval soon or big pharma will push to buy Theralase within the next 1 to 2 years. I personally love the science but have been very disappointed by the lack of progess over many years. This science needs to be released to help the many patients in need.